India to Canada: Doxorubicin Export Trade Route
India has recorded 22 verified shipments of Doxorubicin exported to Canada, representing a combined trade value of $12.7M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $578.6K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 61% of total export value with 9 shipments worth $7.7M USD. On the buying side, TARO PHARMACEUTICALS INC. is the largest importer in Canada with $6.9M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , INTAS PHARMACEUTICALS LTD — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Doxorubicin corridor is one of India's established pharmaceutical export routes, with 22 shipments documented worth a combined $12.7M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's doxorubicin manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $578.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with doxorubicin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 27.9%, placing it at rank #2 among India's top doxorubicin export destinations globally.
On the import side, key buyers of Indian doxorubicin in Canada include TARO PHARMACEUTICALS INC., TARO PHARMACEUTICAL INC. , TARO PHARMACEUTICALS INC and 6 others. TARO PHARMACEUTICALS INC. is the single largest importer with 8 shipments valued at $6.9M USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#2
- Annual growth+27.9%
- Demand growth+23.4%
- Regulatory ease81/100
Top 10 Indian Doxorubicin Exporters to Canada
Showing top 10 of 5 Indian suppliers exporting Doxorubicin to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $857.5K per shipment | 9 | $7.7M | 60.6% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $798.2K per shipment | 6 | $4.8M | 37.6% |
| 3 | INTAS PHARMACEUTICALS LTD Avg $41.5K per shipment | 3 | $124.4K | 1.0% |
| 4 | CHANDRA BHAGAT PHARMA LIMITED Avg $31.6K per shipment | 3 | $94.8K | 0.7% |
| 5 | INTAS PHARMACEUTICALS LIMITED Avg $3.6K per shipment | 1 | $3.6K | 0.0% |
This table shows the top 10 of 5 Indian companies exporting doxorubicin to Canada, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , INTAS PHARMACEUTICALS LTD, CHANDRA BHAGAT PHARMA LIMITED , INTAS PHARMACEUTICALS LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 9 shipments worth $7.7M USD, giving it a 61% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Doxorubicin Importers in Canada
Showing top 10 of 9 known buyers in Canada receiving Doxorubicin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian doxorubicin in Canada include TARO PHARMACEUTICALS INC., TARO PHARMACEUTICAL INC. , TARO PHARMACEUTICALS INC , TARO PHARMACEUTICALS INC. , TARO PHARMACEUTICALS INC, among 9 total buyers. The largest importer is TARO PHARMACEUTICALS INC., accounting for $6.9M USD across 8 shipments — representing 54% of all doxorubicin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TARO PHARMACEUTICALS INC. | 8 | $6.9M | 54.1% |
| 2 | TARO PHARMACEUTICAL INC. | 3 | $2.4M | 18.6% |
| 3 | TARO PHARMACEUTICALS INC | 1 | $1.6M | 12.5% |
| 4 | TARO PHARMACEUTICALS INC. | 2 | $834.0K | 6.6% |
| 5 | TARO PHARMACEUTICALS INC | 1 | $824.7K | 6.5% |
| 6 | ACCORD HEALTHCARE INC | 1 | $118.4K | 0.9% |
| 7 | TO THE ORDER | 3 | $94.8K | 0.7% |
| 8 | Accord Healthcare Inc | 2 | $6.0K | 0.0% |
| 9 | ACCORD HEALTHCARE INC., | 1 | $3.6K | 0.0% |
Top 10 Doxorubicin Formulations Imported by Canada
Showing top 10 of 15 product formulations shipped on the India to Canada Doxorubicin route, ranked by trade value
Canada imports a wide range of doxorubicin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOME — accounts for $4.8M USD across 6 shipments. There are 15 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOME | 6 | $4.8M | 37.6% |
| 2 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [10516 PACK X 1 VIAL] | 1 | $1.8M | 14.4% |
| 3 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [7082 PACKX 1 VIAL] | 1 | $1.2M | 9.8% |
| 4 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION 20MG/10ML (2MG/ML) [3558 PACKX 1 VIAL]VLS | 1 | $837.6K | 6.6% |
| 5 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION 20MG/10 ML 2MG/ML [3501 PACK X 1 VIAL] | 1 | $824.7K | 6.5% |
| 6 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION 20MG/10ML (2MG/ML) [3427 PACKX 1 VIAL]VLS | 1 | $806.9K | 6.3% |
| 7 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [3586 PACKS X 1 VIAL] | 1 | $632.8K | 5.0% |
| 8 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [3631 PACKX 1 VIAL] | 1 | $622.5K | 4.9% |
| 9 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [3415 PACKX 1 VIAL] | 1 | $600.1K | 4.7% |
| 10 | TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [1756 PACKX 1 VIAL] | 1 | $306.2K | 2.4% |
Showing top 10 of 15 Doxorubicin formulations imported by Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 10 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's doxorubicin exports to Canada are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , INTAS PHARMACEUTICALS LTD — together account for 99% of total trade value on this route. The average shipment value of $578.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as taro-doxorubicin hydrochloride liposomeinjection, 20mg/10ml (2mg/ml) [10516 pack x 1 vial] and taro-doxorubicin hydrochloride liposomeinjection, 20mg/10ml (2mg/ml) [7082 packx 1 vial], suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TARO PHARMACEUTICALS INC. is the largest importer with 8 shipments worth $6.9M USD — representing 54% of all doxorubicin imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $12.7M
- Avg. Shipment
- $578.6K
- Suppliers
- 5
- Buyers
- 9
- Transit (Sea)
- ~24 days
- Annual Growth
- +27.9%
Related Analysis
Reverse Direction
Canada → India — Doxorubicin (Import)Other Doxorubicin Routes
Unlock the Full India to Canada Doxorubicin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 22 shipments on this route.
Frequently Asked Questions — India to Canada Doxorubicin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Doxorubicin to Canada?
The leading Indian exporters of Doxorubicin to Canada are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , INTAS PHARMACEUTICALS LTD. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 61% of total trade value on this route.
Q What is the total value of Doxorubicin exports from India to Canada?
India exports Doxorubicin to Canada worth approximately $12.7M USD across 22 recorded shipments. The average value per shipment is $578.6K USD.
Q Which ports does India use to ship Doxorubicin to Canada?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 10 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Canada for Doxorubicin?
The average transit time for Doxorubicin shipments from India to Canada is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Canada Doxorubicin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.9% with demand growth tracking at 23.4%. The route is ranked #2 among India's top Doxorubicin export destinations globally.
Q How many suppliers are active on the India to Canada Doxorubicin route?
There are currently 5 active Indian suppliers exporting Doxorubicin to Canada. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 61% of total shipment value.
Q Who are the main importers of Doxorubicin from India in Canada?
The leading importers of Indian Doxorubicin in Canada include TARO PHARMACEUTICALS INC., TARO PHARMACEUTICAL INC. , TARO PHARMACEUTICALS INC , TARO PHARMACEUTICALS INC. , TARO PHARMACEUTICALS INC. TARO PHARMACEUTICALS INC. is the largest buyer with 8 shipments worth $6.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Doxorubicin.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 9 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 22 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
22 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists